ECS 0.00% 1.7¢ ecs botanics holdings ltd

Ann: ECS launches B2C sales, page-13

  1. 1,902 Posts.
    lightbulb Created with Sketch. 614
    Will be interesting to see how much share of the B2C domestic market ECS can pickup with their sales team in place. Cannatrek says their doctor liaison team is invaluable. I used to date a pharmaceutical sales rep who went to pitch her company's medications to doctors. Need to get your product front of mind for prescribers and I think Vesisorb will be a big standout as it's been peer-reviewed in the journal of medicine and there is nothing else like it in market. When it comes to prescribing a product for a patient they will be now be able to recommend a faster-acting drug with higher efficacy than the other 999 products that are basically the same thing.

    If I were a sales rep I would walk into meetings with doctors, give them a copy of the research and tell them that this is the new, safer way to treat patients. Safer as it requires a lower dose for the same effect.
 
watchlist Created with Sketch. Add ECS (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.000(0.00%)
Mkt cap ! $21.90M
Open High Low Value Volume
1.8¢ 1.8¢ 1.6¢ $93.61K 5.542M

Buyers (Bids)

No. Vol. Price($)
16 3951221 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 17785 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ECS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.